New SARS-CoV-2 variant Eris on the rise
SARS-CoV-2 lineage EG.5.1 has an advantage at evading neutralizing antibodies
18-Sep-2023 -
As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells. In response, the virus develops mutations that cause antibodies to bind less effectively to the spike ...
antibodies
coronaviruses
Covid-19
+3